Yinghua Ji

Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial

Zhihao Lü, Junye Wang, Yongqian Shu et al. · BMJ · 2022 · 480 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer

Ying Cheng, Liang Han, Lin Wu et al. · JAMA · 2022 · 456 citations · Full text

Medicine, Oncology, Pharmacology +17

AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With <i>EGFR</i> Exon 19 Deletion or L858R Mutations

Shun Lü, Xiaorong Dong, Hong Jian et al. · Journal of Clinical Oncology · 2022 · 279 citations · Full text

Medicine, Oncology, Pharmacology +16

A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trial

Yuxiang Ma, Yunpeng Yang, Yan Huang et al. · Nature Medicine · 2025 · 76 citations · Full text

Medicine, Oncology, Pharmacology +17

Screening of MicroRNA in Patients with Esophageal Cancer at Same Tumor Node Metastasis Stage with Different Prognoses

Baosheng Zhao, Shangguo Liu, Tianyun Wang et al. · Asian Pacific Journal of Cancer Prevention · 2013 · 67 citations · Full text

Medicine, Oncology, Pathology +17